Skip to main content

Pfizer Venture Investments — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

52
Companies
$2.1B
Total invested
$50.3M
Avg. check
24
Industries
Biotechnology 22Therapeutics 11Pharmaceutical 9Biopharma 7Health Care 7Life Science 5+18 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 52
ReCode Therapeutics
September 2025

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

Biopharma · Dallas$29.4M Debt Financing
Levicept
September 2021

Levicept develops biological agent for the treatment of chronic pain.

Biopharma · Sandwich$47.8M Series B
Anjarium Biosciences
September 2021

Anjarium is focused on creating new class of non-viral gene therapies to deliver predictable ,inclusionary ways to tackle genetic diseases.

Biotechnology · Schlieren$60.4M Series A
Strata Oncology
July 2021

Strata Oncology is a precision oncology company dedicated to transforming cancer care.

Biotechnology · Ann Arbor$90.0M Series C
Rhythm Pharmaceuticals
July 2025

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics

Biotechnology · Boston$175.0M Post-IPO Equity
Mozart Therapeutics
June 2023

Mozart is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases.

Biotechnology · Seattle$25.0M Series A
Engine Biosciences
June 2026

Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.

Artificial Intelligence (AI) · SingaporeVenture - Series Unknown
Oblenio Bio
June 2026

Oblenio Bio is a biotechnology company that develops T-cell engager therapeutic candidates for autoimmune disease treatment.

Biopharma · Oakland$62.0M Series B
DEM BioPharma
June 2022

DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.

Biotechnology · Cambridge$70.0M Series A
Cour Pharmaceuticals Development
June 2026

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

Biotechnology · Skokie$50.0M Series B
DAIVIN
March 2026

Daivin is an oxygen-generating equipment manufacturing company which helps humans breathe underwater without oxygen tanks.

Aerospace · San FranciscoPre-Seed
Flare Therapeutics
March 2023

Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.

Biopharma · Cambridge$123.0M Series B
MindImmune Therapeutics
March 2026

MindImmune Therapeutics is a pharmaceutical company developing drugs to treat diseases of the central nervous system.

Biotechnology · Providence$5.0M Grant
Curve Therapeutics
February 2024

Curve develops an innovative screening platform.

Biotechnology · Southampton$51.4M Series A
NexImmune
February 2024

NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.

Biopharma · Gaithersburg$3.7M Post-IPO Equity
Arkuda Therapeutics
February 2022

Arkuda Therapeutics is a pharmaceutical company.

Biotechnology · Cambridge$64.0M Series B
Enodia Therapeutics
January 2026

Enodia Therapeutics is a biotech company that provides transforming treatments for cancer, inflammation, and viral infection diseases.

Biotechnology · Paris$24.2M Seed
FoRx Therapeutics
December 2025

FoRx Therapeutics is a biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress pathways.

Biotechnology · Basel$50.0M Series A
Anaveon
December 2021

Anaveon is a developing IL-2 complexes which selectively promote effector T cell functions.

Therapeutics · Bottmingen$119.7M Series B
Kestrel Therapeutics
December 2021

Kestrel Therapeutics is a medical research and devenlopment company that offers treatment solutions for RAS cancers.

Biopharma · Allston$40.0M Series A
Parthenon Therapeutics
November 2021

Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.

Biotechnology · Cambridge$65.0M Series A
VitaDAO
November 2023

A decentralized collective funding early stage aging research & spinning out longevity biotech startups to extend healthy lifespan

Biotechnology · Ottawa$2.0M Seed
Enara Bio
October 2024

Ervaxx is illuminating the immune interface to develop new cancer therapies.

Biopharma · Oxford$32.5M Series B
Nucleome Therapeutics
October 2022

Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases

Biotechnology · Oxford$42.0M Series A

Where Pfizer Venture Investments invests

Biotechnology22
Therapeutics11
Pharmaceutical9
Biopharma7
Health Care7
Life Science5

About Pfizer Venture Investments's portfolio

How many companies has Pfizer Venture Investments invested in?

Pfizer Venture Investments has invested in 52 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Pfizer Venture Investments invest in?

Pfizer Venture Investments's top investment sectors include Biotechnology, Therapeutics, Pharmaceutical, Biopharma, Health Care. The firm invests across 24 different industry categories.

What is Pfizer Venture Investments's largest investment?

Among tracked funding rounds, Rhythm Pharmaceuticals received $175.0M in a Post-IPO Equity round. Pfizer Venture Investments's total known invested capital is $2.1B.

What is the average investment size for Pfizer Venture Investments?

Pfizer Venture Investments's average investment size is $50.3M across its portfolio of 52 companies.

What are Pfizer Venture Investments's most recent investments?

Recent Pfizer Venture Investments portfolio additions include ReCode Therapeutics, Levicept, Anjarium Biosciences, Strata Oncology, Rhythm Pharmaceuticals. These companies were founded in 2020 or later.

Reach the founders behind these 52 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →